EA
SRDX

Emerald Acquisition’s Surmodics SRDX Stock Holding History

Emerald Acquisition’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$5.17M Sell
171,865
-23,192
-12% -$637K 0.01% 1193
2016
Q2 		$4.58M Buy
+195,057
New +$4.27M 0.01% 1381

Other funds holding SRDX

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Emerald Acquisition's SRDX Position: Q3 2016 in Review

Emerald Acquisition reduced its Surmodics (SRDX) stake by 12% in Q3 2016, selling an estimated $637K and leaving 171,865 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #1193.

Emerald Acquisition first reported a position in SRDX in Q2 2016 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold SRDX as of Q3 2016.

  • Emerald Acquisition held 171,865 shares of Surmodics worth $5.17M as of Q3 2016.
  • Emerald Acquisition sold 23,192 Surmodics shares in Q3 2016, an estimated $637K.
  • Surmodics made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1193 holding.
  • Emerald Acquisition first reported a position in Surmodics in Q2 2016 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held Surmodics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.